Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 20;9:e2300010. doi: 10.1200/GO.23.00010

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG 3 — Distribution of responses on treatment guidelines followed before and during the COVID surge among 1,103 respondents regarding an invasive BC after mastectomy with immediate reconstruction case 3. A 54-year-old woman underwent a total simple mastectomy with immediate tissue expander reconstruction. Pathology revealed a 3.4-cm grade 2 ER+/PR+/HER2– invasive ductal carcinoma and no lymphovascular invasion. Of three sentinel lymph nodes, one was positive (8-mm focus) without extranodal extension. Oncotype Dx recurrence score was 4. Adjuvant chemotherapy was not recommended. An adjuvant aromatase inhibitor was planned. ^aResponses regarding treatment recommendation are shown. BC, breast cancer; ER+, estrogen receptor–positive; HER2–, human epidermal growth factor receptor 2–negative; PMRT, postmastectomy radiation therapy; PR+, progesterone receptor–positive.